Proteomic Profiling of a Biomimetic Drug Delivery Platform.

Proteomic Profiling of a Biomimetic Drug Delivery Platform.

Item
http://www.wikidata.org/entity/Q38941645
The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug deliveryCell source determines the immunological impact of biomimetic nanoparticles.Biomimetic carriers mimicking leukocyte plasma membrane to increase tumor vasculature permeability.Multistage vector (MSV) therapeutics.Biomimetic proteolipid vesicles for targeting inflamed tissuesEnabling cytoplasmic delivery and organelle targeting by surface modification of nanocarriers.Effects of the protein corona on liposome-liposome and liposome-cell interactions.The Emerging Role of Nanotechnology in Cell and Organ Transplantation.Nanoantibiotics: a new paradigm for the treatment of surgical infection.Post-nano strategies for drug delivery: Multistage porous silicon microvectors.Inflammation and Cancer: In Medio Stat Nano.Engineered biomimetic nanovesicles show intrinsic anti-inflammatory properties for the treatment of inflammatory bowel diseases.Enhancing cancer immunotherapy through nanotechnology-mediated tumor infiltration and activation of immune cells.Trends towards Biomimicry in Theranostics
P2860

Proteomic Profiling of a Biomimetic Drug Delivery Platform.

Item
http://www.wikidata.org/entity/Q38941645
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Proteomic Profiling of a Biomimetic Drug Delivery Platform.
@en
type
label
Proteomic Profiling of a Biomimetic Drug Delivery Platform.
@en
prefLabel
Proteomic Profiling of a Biomimetic Drug Delivery Platform.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Proteomic Profiling of a Biomimetic Drug Delivery Platform.
@en
P2093
P2860
P304
P31
P356
10.2174/1389450115666141109211413
P433
P478
P50
P577
P5875
P698
P921
P932